Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

A History of Radionuclide Studies in the UKA History of Nuclear Medicine in the UK Radionuclide Investigation of the Brain

A History of Radionuclide Studies in the UK: A History of Nuclear Medicine in the UK Radionuclide... [In the UK, the institute of Nuclear Medicine in London has played an important role in the development of radionuclide investigation of brain. This chapter summarises the very early days of blood brain barrier imaging with labelled pertechnetate, and the use of 3" and 5" sodium iodide crystal scanners in the 60’s, with added simple data processing in the 70’s, progress was continuous, with the introduction of SPET, lyphophilic Tc99m labelled tracers for blood flow studies, the emergence of dopamine transporter imaging in patients with presumed Parkinson’s disease, followed by PET/CT and assessment of glucose metabolism with labelled FDG, and finally the UK introduction of PET/MR and the investigation of the dementias, with labelled amyloid.] http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png

A History of Radionuclide Studies in the UKA History of Nuclear Medicine in the UK Radionuclide Investigation of the Brain

Editors: McCready, Ralph; Gnanasegaran, Gopinath; Bomanji, Jamshed B.

Loading next page...
 
/lp/springer-journals/a-history-of-radionuclide-studies-in-the-uk-a-history-of-nuclear-NJS8cG00F3

References (9)

Publisher
Springer International Publishing
Copyright
© The Editor(s) (if applicable) and the Author(s) 2016. This book is published open access.
ISBN
978-3-319-28623-5
Pages
47 –52
DOI
10.1007/978-3-319-28624-2_7
Publisher site
See Chapter on Publisher Site

Abstract

[In the UK, the institute of Nuclear Medicine in London has played an important role in the development of radionuclide investigation of brain. This chapter summarises the very early days of blood brain barrier imaging with labelled pertechnetate, and the use of 3" and 5" sodium iodide crystal scanners in the 60’s, with added simple data processing in the 70’s, progress was continuous, with the introduction of SPET, lyphophilic Tc99m labelled tracers for blood flow studies, the emergence of dopamine transporter imaging in patients with presumed Parkinson’s disease, followed by PET/CT and assessment of glucose metabolism with labelled FDG, and finally the UK introduction of PET/MR and the investigation of the dementias, with labelled amyloid.]

Published: Mar 10, 2016

Keywords: Single Photon Emission Tomography; Focal Epilepsy; Brain Blood Flow; Blood Flow Study; Dopamine Transporter Imaging

There are no references for this article.